COL17A1 and melanoma: The presence of a putative association between BP and melanoma was also postulated in view of several experimental and serological findings like the expression of BP180 in malignant melanocytes [11], the progression of melanoma in a mouse strain with BP180 dysfunction [12], and the increased seropositivity of anti-BP230 autoantibodies among melanoma patients [13].